<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13A-17 OR 15D-17 THEREUNDER
Quest Medical, Inc.
--------------------------------------------------
(Exact name of issuer as specified in charter)
One Allentown Parkway, Allen, Texas 75002
--------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (214) 390-9800
---------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security: Common Stock, par value $0.05 per share
2. Number of shares outstanding before the change: 6,146,776
3. Number of shares outstanding after the change: 7,754,121
4. Effective date of change: See Items 5(a)(b)(c) below.
5. Method of change:
(a) Shares issued upon exercise of Stock Options. Quest has
issued 90,678 shares of its Common Stock from time to
time since April 7, 1995 (the date of its last Form 10-C
filing).
(b) On November 15, 1995 Quest issued 200,000 shares of its Common
Stock as "earn-out" consideration in connection with its
acquisition of Neuromed, Inc. The shares were issued from
Quest's treasury shares.
(c) On November 15, 1995, Quest issued 1,316,667 shares in
connection with a public offering of Quest Common Stock. The
shares were issued from Quest's treasury shares. The balance
of shares in the Quest offering were sold by selling
shareholders.
QUEST MEDICAL, INC.
Date: November 21, 1995 By: /s/ F. Robert Merrill III
-----------------------------
F. Robert Merrill III
Chief Financial Officer
